Canada sees HIV plant funds redirected to research

Millions of dollars once earmarked for a Canadian HIV vaccine-production facility now will be spent on research and preventing mother-to-child transmission of the virus, Health Minister Leona Aglukkaq has announced.  A partnership between the federal government and the Gates Foundation had set aside $88 million for a lab to produce pilot HIV vaccines, but the program was cancelled in February. That decision triggered controversy among scientists, as well as some harsh criticism from the companies that hoped to win the contract to build and operate it. Story